MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
16,168,144
Share change
-820,875
Total reported value
$90,043,402
Price per share
$5.57
Number of holders
67
Value change
-$4,561,887
Number of buys
33
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q3 2016

As of 30 Sep 2016, MEDGENICS INC - COM NEW (MDGN) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,168,144 shares. The largest 10 holders included Broadfin Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Opaleye Management Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and SPHERA FUNDS MANAGEMENT LTD.. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.